NIA
NVO

NIA Impact Advisors’s Novo Nordisk NVO Stock Holding History

NIA Impact Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,900
Closed -$1.17M – 102
2025
Q4 		$1.17M Hold
22,900
– – 0.39% 64
2025
Q3 		$1.27M Buy
22,900
+200
+0.9% +$11.7K 0.41% 63
2025
Q2 		$1.57M Sell
22,700
-200
-0.9% -$13.6K 0.54% 59
2025
Q1 		$1.59M Sell
22,900
-300
-1% -$24.8K 0.59% 61
2024
Q4 		$2M Buy
23,200
+415
+2% +$44.9K 0.65% 56
2024
Q3 		$2.71M Sell
22,785
-544
-2% -$72.5K 0.9% 39
2024
Q2 		$3.33M Buy
23,329
+1,145
+5% +$152K 1.2% 26
2024
Q1 		$2.85M Buy
+22,184
New +$2.64M 1.14% 30

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

NIA Impact Advisors's NVO Position: Q1 2026 in Review

NIA Impact Advisors sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 22,900 shares — an estimated $1.17M sold.

NIA Impact Advisors first reported a position in NVO in Q1 2024 and held it in 8 quarters. The position peaked at $3.33M in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • NIA Impact Advisors reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • NIA Impact Advisors sold 22,900 Novo Nordisk shares in Q1 2026, an estimated $1.17M.
  • NIA Impact Advisors first reported a position in Novo Nordisk in Q1 2024 and held it in 8 quarters.
  • NIA Impact Advisors's Novo Nordisk position peaked at $3.33M in Q2 2024.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on NIA Impact Advisors's 13F filing for Q1 2026, filed 8 May 2026.